Works by Huang, Chiun-Sheng

Results: 86
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial).

    Published in:
    BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11291-6
    By:
    • Kuo, Sung-Hsin;
    • Tseng, Ling-Ming;
    • Chen, Shou-Tung;
    • Sagara, Yasuaki;
    • Chang, Yuan-Ching;
    • Yeh, Hsien-Tang;
    • Kuo, Yao-Lung;
    • Hung, Chih-Chiang;
    • Lu, Tzu-Pin;
    • Lee, Yi-Hsuan;
    • Toi, Masakazu;
    • Huang, Chiun-Sheng
    Publication type:
    Article
    12
    13
    14
    15

    Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00477-z
    By:
    • Loibl, Sibylle;
    • Huang, Chiun-Sheng;
    • Mano, Max S.;
    • Mamounas, Eleftherios P.;
    • Geyer Jr, Charles E.;
    • Untch, Michael;
    • Thery, Jean-Christophe;
    • Schwaner, Ingo;
    • Limentani, Steven;
    • Loman, Niklas;
    • Lübbe, Kristina;
    • Chang, Jenny C.;
    • Hatschek, Thomas;
    • Tesarowski, David;
    • Song, Chunyan;
    • Lysbet de Haas, Sanne;
    • Boulet, Thomas;
    • Lambertini, Chiara;
    • Wolmark, Norman
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Concurrent epirubicin and trastuzumab use increases complete pathological response rate without additional cardiotoxicity in patients with human epidermal growth factor receptor 2‐positive early breast cancer: A meta‐regression analysis.

    Published in:
    Cancer Medicine, 2024, v. 13, n. 14, p. 1, doi. 10.1002/cam4.70005
    By:
    • Yang, Ming‐Han;
    • Huang, Chiun‐Sheng;
    • Chang, Dwan‐Ying;
    • Hu, Fu‐Chang;
    • Huang, Shu‐Min;
    • Huang, Po‐Hsiang;
    • Chen, I‐Chun;
    • Chen, Tom Wei‐Wu;
    • Lin, Ching‐Hung;
    • Lu, Yen‐Shen
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40

    Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early breast cancer.

    Published in:
    Therapeutic Advances in Medical Oncology, 2023, v. 15, p. 1, doi. 10.1177/17588359231178125
    By:
    • Slamon, Dennis J.;
    • Fasching, Peter A.;
    • Hurvitz, Sara;
    • Chia, Stephen;
    • Crown, John;
    • Martín, Miguel;
    • Barrios, Carlos H.;
    • Bardia, Aditya;
    • Im, Seock-Ah;
    • Yardley, Denise A.;
    • Untch, Michael;
    • Huang, Chiun-Sheng;
    • Stroyakovskiy, Daniil;
    • Xu, Binghe;
    • Moroose, Rebecca L.;
    • Loi, Sherene;
    • Visco, Frances;
    • Bee-Munteanu, Valerie;
    • Afenjar, Karen;
    • Fresco, Rodrigo
    Publication type:
    Article
    41

    Efficacy and safety results by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2−, node-positive, high-risk early breast cancer.

    Published in:
    Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231151840
    By:
    • Paluch-Shimon, Shani;
    • Neven, Patrick;
    • Huober, Jens;
    • Cicin, Irfan;
    • Goetz, Matthew P.;
    • Shimizu, Chikako;
    • Huang, Chiun-Sheng;
    • Lueck, Hans Joachim;
    • Beith, Jane;
    • Tokunaga, Eriko;
    • Contreras, Jessica Reyes;
    • de Sant'Ana, Rosane Oliveira;
    • Wei, Ran;
    • Shahir, Ashwin;
    • Nabinger, Sarah C.;
    • Forrester, Tammy;
    • Johnston, Stephen R. D.;
    • Harbeck, Nadia
    Publication type:
    Article
    42

    Patient‐reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2–positive breast cancer

    Published in:
    2020
    By:
    • Conte, PierFranco;
    • Schneeweiss, Andreas;
    • Loibl, Sibylle;
    • Mamounas, Eleftherios P.;
    • Minckwitz, Gunter;
    • Mano, Max S.;
    • Untch, Michael;
    • Huang, Chiun‐Sheng;
    • Wolmark, Norman;
    • Rastogi, Priya;
    • D'Hondt, Veronique;
    • Redondo, Andrés;
    • Stamatovic, Ljiljana;
    • Bonnefoi, Hervé;
    • Castro‐Salguero, Hugo;
    • Fischer, Hans H.;
    • Wahl, Tanya;
    • Song, Chunyan;
    • Boulet, Thomas;
    • Trask, Peter
    Publication type:
    journal article
    43
    44
    45
    46
    47
    48
    49
    50